Chennai Meenakshi Multispeciality Hospital Ltd

Chennai Meenakshi Multispeciality Hospital Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 23 February 2026, driven primarily by a shift in technical indicators despite ongoing challenges in financial performance. The healthcare services company’s Mojo Score rose to 33.0, reflecting a cautious but improved outlook amid mixed signals from valuation and financial trends.

Chennai Meenakshi Multispeciality Hospital Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 16 Feb 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. The healthcare services company’s Mojo Score fell to 23.0, signalling heightened risk for investors amid sideways technical trends and flat financial performance.

Chennai Meenakshi Multispeciality Hospital Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators despite ongoing fundamental challenges. The company’s technical trend has improved from mildly bearish to mildly bullish, prompting a reassessment of its outlook. However, financial performance remains flat, and valuation concerns persist, underscoring a cautious stance for investors.

Chennai Meenakshi Multispeciality Hospital Ltd., a micro-cap healthcare services provider operating a 100-bed facility in Chennai's Mylapore locality, returned to profitability in Q2 FY26 with a net profit of ₹0.15 crores, reversing the ₹0.74 crores loss posted in the previous quarter. However, the achievement masks deeper structural concerns about the company's financial viability, with negative book value of ₹1.89 crores and a troubling history of inconsistent profitability that continues to weigh on investor sentiment.

Chennai Meenakshi Multispeciality Hospital Ltd has been downgraded from a Sell to a Strong Sell rating as of 6 February 2026, reflecting deteriorating technical indicators and stagnant financial performance. The healthcare services company’s Mojo Score has declined to 17.0, signalling heightened risk for investors amid a challenging market environment and weak fundamentals.

Chennai Meenakshi Multispeciality Hospital Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 1 February 2026, driven primarily by a shift in technical indicators despite persistent fundamental challenges. The healthcare services company’s Mojo Score improved to 33.0, reflecting a mildly bullish technical trend, although its long-term financial health and valuation metrics remain concerning for investors.

Chennai Meenakshi Multispeciality Hospital Ltd has been downgraded from a Sell to a Strong Sell rating as of 22 Jan 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. Despite a modest day gain of 1.06% to ₹43.00, the stock continues to underperform the broader market and faces significant challenges across quality, valuation, financial trends, and technical parameters.

Chennai Meenakshi Multispeciality Hospital Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Oct 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 26 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Chennai Meena, a microcap player in the Healthcare Services sector, has experienced a revision in its market evaluation reflecting nuanced shifts across key analytical parameters. This adjustment follows a detailed assessment of the company’s quality, valuation, financial trends, and technical outlook, offering investors a clearer perspective on its current standing.

Chennai Meenakshi Multispeciality Hospital Ltd is currently experiencing a pronounced selling pressure, with the stock registering a lower circuit and an absence of buyers in the market. This distress selling scenario highlights significant investor caution despite the healthcare sector's overall steadiness.

Chennai Meenakshi Multispeciality Hospital has encountered significant selling pressure in recent trading sessions, with the stock registering no buying interest and only sell orders queued. This unusual market behaviour signals distress selling and raises concerns about investor sentiment towards the healthcare services provider.

Chennai Meenakshi Multispeciality Hospital has attracted extraordinary buying interest, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals strong investor enthusiasm and the potential for a multi-day circuit scenario, setting the healthcare services stock apart amid mixed sector and benchmark performances.

Chennai Meenakshi Multispeciality Hospital has attracted remarkable buying interest today, with the stock hitting an upper circuit and registering only buy orders in the queue. This unusual market activity signals a potential multi-day circuit scenario, reflecting strong demand despite recent price volatility and sector underperformance.

Chennai Meenakshi Multispeciality Hospital Ltd has entered an extraordinary phase of market activity, registering an upper circuit scenario characterised by exclusively buy orders in the queue. This rare event highlights intense buying interest with no sellers willing to part with shares, signalling a potential multi-day circuit situation for the healthcare services stock.